Your browser doesn't support javascript.
loading
ACE inhibitors and ARBs: Managing potassium and renal function.
Momoniat, Tasnim; Ilyas, Duha; Bhandari, Sunil.
Afiliação
  • Momoniat T; Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, United Kingdom.
  • Ilyas D; Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, United Kingdom.
  • Bhandari S; Department of Nephrology, Hull Royal Infirmary, Hull University Teaching Hospitals NHS Trust, East Yorkshire, United Kingdom. Sunil.Bhandari@hey.nhs.uk.
Cleve Clin J Med ; 86(9): 601-607, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31498767
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are used primarily to treat hypertension and are also useful for conditions such as heart failure and chronic kidney disease, independent of their effect on blood pressure. This article reviews the indications for ACE inhibitors and ARBs and offers advice for managing their adverse effects, particularly declining renal function and hyperkalemia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Potássio / Inibidores da Enzima Conversora de Angiotensina / Antagonistas de Receptores de Angiotensina / Taxa de Filtração Glomerular / Hiperpotassemia Limite: Humans Idioma: En Revista: Cleve Clin J Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Potássio / Inibidores da Enzima Conversora de Angiotensina / Antagonistas de Receptores de Angiotensina / Taxa de Filtração Glomerular / Hiperpotassemia Limite: Humans Idioma: En Revista: Cleve Clin J Med Ano de publicação: 2019 Tipo de documento: Article